The U.S. Department of Justice alleged that UCLA’s David Geffen School of Medicine intentionally selected applicants based on race in violation of federal civil-rights law and the Supreme Court’s 2023 ban on race-conscious admissions. In a findings letter, DOJ accused the school of preferencing Black and Hispanic applicants while discriminating against other applicants. UCLA’s response says the process is merit-based and follows federal and state requirements, while the DOJ points to application questions designed to invite students to identify as part of a marginalized group and discuss impact—citing them as mechanisms to reveal race. The complaint includes comparisons of admitted-student GPAs and test scores across racial categories. The enforcement escalation comes as the Trump administration broadens investigations into medical school admissions practices, including previously cited scrutiny of other universities. For higher education institutions, the headline risk is operational: admissions offices may need tighter compliance controls over forms, prompts, and how reviewers use contextual information under the post-affirmative-action framework.